Ott O - Search Results

1

Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial.

Strnad V, Ott O, Pötter R, Hildebrandt G, Hammer J, Resch A, Lotter M, Ackermann S, Beckmann MW, Sauer R. Strnad V, et al. Among authors: ott o. Brachytherapy. 2004;3(3):115-9. doi: 10.1016/j.brachy.2004.08.003. Brachytherapy. 2004. PMID: 15533801 Clinical Trial.

2

Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial.

Issels RD, Boeck S, Pelzer U, Mansmann U, Ghadjar P, Lindner LH, Albertsmeier M, Angele MK, Schmidt M, Xu Y, Bahra M, Pratschke J, Schoenberg M, Thasler WE, Salat C, Stoetzer OJ, Knoefel WT, Graf D, Wessalowski R, Keitel-Anselmino V, Koenigsrainer A, Bitzer M, Zips D, Bamberg M, Fietkau R, Ott O, Kawecki M, Wyrwicz L, Rutkowski P, Rentsch M, Ababei J, Reichardt P, Rigamonti M, Weber B, Abdel-Rahman S, Tschoep-Lechner K, Jauch KW, Bruns CJ, Oettle H, von Bergwelt-Baildon M, Heinemann V, Werner J; European Society for Hyperthermic Oncology (ESHO) and the German Arbeitsgemeinschaft Internistische Onkologie (AIO) Study Group for Pancreatic Cancer. Issels RD, et al. Among authors: ott o. Eur J Cancer. 2023 Mar;181:155-165. doi: 10.1016/j.ejca.2022.12.009. Epub 2022 Dec 30. Eur J Cancer. 2023. PMID: 36657324 Clinical Trial.

3

[Partial breast irradiation for early breast cancer with favorable prognostic factors: 3-year results of the German-Austrian phase II-trial].

Ott OJ, Pötter R, Hildebrandt G, Hammer J, Lotter M, Beckmann MW, Sauer R, Strnad V. Ott OJ, et al. Rofo. 2005 Jul;177(7):962-7. doi: 10.1055/s-2005-858268. Rofo. 2005. PMID: 15973598 Clinical Trial. German.

4

Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients.

Strnad V, Melzner W, Geiger M, Zenk J, Waldfahrer F, Lotter M, Ott O, Seeger A, Iro H, Sauer R. Strnad V, et al. Among authors: ott o. Strahlenther Onkol. 2005 Dec;181(12):762-7. doi: 10.1007/s00066-005-1424-5. Strahlenther Onkol. 2005. PMID: 16362785 Clinical Trial.

5

Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy.

Weiss C, Rödel F, Ott O, Engehausen DG, Papadopoulos T, Sauer R, Rödel C. Weiss C, et al. Among authors: ott o. Strahlenther Onkol. 2007 Oct;183(10):552-6. doi: 10.1007/s00066-007-1766-2. Strahlenther Onkol. 2007. PMID: 17896086

6

Radiochemotherapy for bladder cancer.

Ott OJ, Rödel C, Weiss C, Wittlinger M, St Krause F, Dunst J, Fietkau R, Sauer R. Ott OJ, et al. Clin Oncol (R Coll Radiol). 2009 Sep;21(7):557-65. doi: 10.1016/j.clon.2009.05.005. Epub 2009 Jun 28. Clin Oncol (R Coll Radiol). 2009. PMID: 19564101 Review.

7

Calcifying tendonitis of the shoulder joint : predictive value of pretreatment sonography for the response to low-dose radiotherapy.

Adamietz B, Schulz-Wendtland R, Alibek S, Uder M, Sauer R, Ott O, Keilholz L. Adamietz B, et al. Among authors: ott o. Strahlenther Onkol. 2010 Jan;186(1):18-23. doi: 10.1007/s00066-009-2025-5. Epub 2009 Dec 28. Strahlenther Onkol. 2010. PMID: 20082183

8

Biological rationales and clinical applications of temperature controlled hyperthermia--implications for multimodal cancer treatments.

Schildkopf P, Ott OJ, Frey B, Wadepohl M, Sauer R, Fietkau R, Gaipl US. Schildkopf P, et al. Among authors: ott oj. Curr Med Chem. 2010;17(27):3045-57. doi: 10.2174/092986710791959774. Curr Med Chem. 2010. PMID: 20629627 Review.

9

Quality assurance for clinical studies in regional deep hyperthermia.

Bruggmoser G, Bauchowitz S, Canters R, Crezee H, Ehmann M, Gellermann J, Lamprecht U, Lomax N, Messmer MB, Ott O, Abdel-Rahman S, Sauer R, Schmidt M, Thomsen A, Wessalowski R, van Rhoon G; ESHO Technical Committee in the Interdisciplinary Working Group Hyperthermia (IAH) in the German Cancer Society. Bruggmoser G, et al. Among authors: ott o. Strahlenther Onkol. 2011 Oct;187(10):605-10. doi: 10.1007/s00066-011-1145-x. Epub 2011 Sep 19. Strahlenther Onkol. 2011. PMID: 21932026

10

Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients.

Keck B, Wach S, Taubert H, Zeiler S, Ott OJ, Kunath F, Hartmann A, Bertz S, Weiss C, Hönscheid P, Schellenburg S, Rödel C, Baretton GB, Sauer R, Fietkau R, Wullich B, Krause FS, Datta K, Muders MH. Keck B, et al. Among authors: ott oj. Int J Cancer. 2015 Jan 15;136(2):443-51. doi: 10.1002/ijc.28987. Epub 2014 Jun 12. Int J Cancer. 2015. PMID: 24862180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters